Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses
Quest Diagnostics has announced it has entered into a definitive agreement to acquire Solstas Lab Partners Group and its subsidiaries for approximately $570 million.
Solstas, a commercial laboratory company based in Greensboro, N.C., is a portfolio company of…
It’s no secret that while some U.S. hospitals are thriving, others are struggling under the weight of decreasing reimbursement, rising expenses and pressures relative to integrated care.
One source of pressure that hits hospitals particularly dependent on Medicare/Medicaid reimbursement was…
Continue Reading AHA Study: Hospitals Losing Substantial Money on Medicare and Medicaid
PE firm Carlyle Group has announced it has agreed to acquire Johnson & Johnson’s Ortho Clinical Diagnostics business for $4.15 billion.
The transaction is expected to close in the middle of 2014.
Ortho Clinical Diagnostics, headquartered in Raritan, N.J.…
Ivantis, Inc. has announced it has raised $46.5 million in series B financing.
Ivantis designs, develops and commercializes technologies to treat glaucoma. It is the developer of the Hydrus microstent device designed to lower eye pressure for glaucoma patients.
Ivantis…
In our most recent Law360 column, we tackled a series of basic investment premises and common misconceptions about investing in the ambulatory surgery center (ASC) industry. This month’s column was co-authored with our McGuireWoods partner Bart Walker and is available…
Continue Reading A Primer for Ambulatory Surgery Center Investors and Lenders
Metabolon, Inc. has announced it has raised $15 million in a series E financing.
Metabolon, headquartered in Research Triangle Park, N.C., provides metabolomics-based diagnostic tests and research services.
New investor Camden Partners, a Baltimore-based PE firm, led the…
Mederi Therapeutics Inc. has announced it has secured $18.5 million in funding comprised of Series B preferred stock and venture debt.
Mederi Therapeutics, based in Greenwich, Conn., manufactures and markets medical devices that deliver radiofrequency energy to treat disease.…
Reuters is reporting that PE firm Carlyle Group LP is close to acquiring Johnson & Johnson’s blood-testing unit.
The deal could be finalized within the next two weeks and worth around $4 billion.
Caryle has struck a number of …
Continue Reading PE Firm Carlyle Group Close to Acquiring J&J Diagnostics Unit
ViewRay Inc. has announced it has secured $30 million in funding.
ViewRay, based in Cleveland, Ohio, is a privately held medical device company developing advanced radiation therapy technology for the treatment of cancer.
The funding came from existing equity…
Consolidation of major healthcare providers in various sectors is not a new phenomenon, but 2013 saw a number of major hospital system mergers that was unusual for the sheer volume of hospitals and dollars involved.
An article from our partner…
